{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:53:43Z","timestamp":1790409223702,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T00:00:00Z","timestamp":1455667200000},"content-version":"vor","delay-in-days":381,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.immuni.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T11:45:20Z","timestamp":1423568720000},"page":"379-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Suppression of Fc\u03b3-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection"],"prefix":"10.1016","volume":"42","author":[{"given":"Douglas H.","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Elsaesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Lux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherie L.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Nimmerjahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2015.01.005_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.160.2.521","article-title":"Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence","volume":"160","author":"Ahmed","year":"1984","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2015.01.005_bib2","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.4049\/jimmunol.1101629","article-title":"An acquired defect in IgG-dependent phagocytosis explains the impairment in antibody-mediated cellular depletion in Lupus","volume":"187","author":"Ahuja","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2015.01.005_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2015.01.005_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2015.01.005_bib6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.immuni.2011.11.009","article-title":"Monocyte subsets responsible for immunoglobulin G-dependent effector functions in\u00a0vivo","volume":"35","author":"Biburger","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2015.01.005_bib7","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1128\/JVI.79.16.10514-10527.2005","article-title":"Intrinsic functional dysregulation of CD4 T\u00a0cells occurs rapidly following persistent viral infection","volume":"79","author":"Brooks","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2015.01.005_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in\u00a0vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2015.01.005_bib9","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines","volume":"2","author":"Burton","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","article-title":"A Blueprint for HIV Vaccine Discovery","volume":"12","author":"Burton","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2015.01.005_bib11","doi-asserted-by":"crossref","first-page":"228ra238","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.immuni.2015.01.005_bib12","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/blood-2003-07-2375","article-title":"Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection","volume":"103","author":"De Milito","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2015.01.005_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in\u00a0vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2015.01.005_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.coi.2010.03.004","article-title":"Opposing positive and negative regulation of T\u00a0cell activity during viral persistence","volume":"22","author":"Fahey","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.20101773","article-title":"Viral persistence redirects CD4 T\u00a0cell differentiation toward T follicular helper cells","volume":"208","author":"Fahey","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2015.01.005_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1783","article-title":"Antiviral antibody responses: the two extremes of a wide spectrum","volume":"6","author":"Hangartner","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nri3689","article-title":"Follicular dendritic cells: dynamic antigen libraries","volume":"14","author":"Heesters","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib19","first-page":"39","article-title":"Antibodies for HIV treatment and prevention: window of opportunity?","volume":"317","author":"Huber","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni911","article-title":"Hypergammaglobulinemia and\u00a0autoantibody induction mechanisms in viral infections","volume":"4","author":"Hunziker","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd3365","article-title":"Advances in the assessment and control of the effector functions of therapeutic antibodies","volume":"10","author":"Jiang","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2015.01.005_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"Klein","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2015.01.005_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2015.01.005_bib24","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.4049\/jimmunol.1302934","article-title":"Inhibitory Fc\u03b3 receptor is required for the maintenance of tolerance through distinct mechanisms","volume":"192","author":"Li","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib25","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","article-title":"Impact of immune complex size and glycosylation on IgG binding to human Fc\u03b3Rs","volume":"190","author":"Lux","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/00002030-199715000-00009","article-title":"Clinical implications of autoantibodies in HIV infection","volume":"11","author":"Massabki","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.immuni.2015.01.005_bib27","doi-asserted-by":"crossref","first-page":"11016","DOI":"10.1128\/JVI.01340-07","article-title":"Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection","volume":"81","author":"Mehandru","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2015.01.005_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.immuni.2015.01.005_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jama.1989.03430060075029","article-title":"The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine","volume":"262","author":"Miotti","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.immuni.2015.01.005_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/00365549850161160","article-title":"Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection","volume":"30","author":"Nielsen","year":"1998","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.immuni.2015.01.005_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib33","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1073\/pnas.1401662111","article-title":"Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection","volume":"111","author":"Osokine","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2015.01.005_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fimmu.2014.00140","article-title":"Antigen cross-presentation of immune complexes","volume":"5","author":"Platzer","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80043-6","article-title":"Neutralizing antibodies have limited effects on the control of established HIV-1 infection in\u00a0vivo","volume":"10","author":"Poignard","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2015.01.005_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.189.2.371","article-title":"Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization","volume":"189","author":"Regnault","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2015.01.005_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nrrheum.2010.68","article-title":"B cells as therapeutic targets in SLE","volume":"6","author":"Sanz","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.immuni.2015.01.005_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/5568","article-title":"Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1\/SIV chimeric virus infections of macaque monkeys","volume":"5","author":"Shibata","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2015.01.005_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI200522753","article-title":"Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?","volume":"115","author":"Siragam","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2015.01.005_bib42","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2015.01.005_bib43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.chom.2012.10.001","article-title":"Chronic bystander infections and immunity to unrelated antigens","volume":"12","author":"Stelekati","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2015.01.005_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2015.01.005_bib45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm1244","article-title":"Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies","volume":"11","author":"Trkola","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2015.01.005_bib46","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1128\/JVI.01792-07","article-title":"In\u00a0vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers","volume":"82","author":"Trkola","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2015.01.005_bib47","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2015.01.005_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2015.01.005_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","article-title":"HIV and autoimmunity","volume":"1","author":"Zandman-Goddard","year":"2002","journal-title":"Autoimmun. Rev."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107476131500031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107476131500031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T16:39:41Z","timestamp":1566319181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107476131500031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S107476131500031X"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2015.01.005","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of Fc\u03b3-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}